See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

Role of Neoadjuvant Targeted Therapies Remains Unclear in NSCLC

Summary by MedPage Today
(MedPage Today) -- Use of neoadjuvant or perioperative immunotherapy in combination with chemotherapy has proven effective for some patients with non-small cell lung cancer (NSCLC), but its role in patients with EGFR- or ALK-mutated disease is...

2 Articles

MedPage TodayMedPage Today
Center

Role of Neoadjuvant Targeted Therapies Remains Unclear in NSCLC

(MedPage Today) -- Use of neoadjuvant or perioperative immunotherapy in combination with chemotherapy has proven effective for some patients with non-small cell lung cancer (NSCLC), but its role in patients with EGFR- or ALK-mutated disease is...

·New York, United States
Read Full Article
cancernetwork.comcancernetwork.com

Outlining Historical Standard Therapies for EGFR-Mutant NSCLC

Osimertinib/chemotherapy and amivantamab/lazertinib have exhibited an efficacy advantage vs osimertinib in patients with EGFR-mutant NSCLC.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

MedPage Today broke the news in New York, United States on Friday, August 1, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

News
For You
SearchBlindspotLocal